Table 4: Pre and post changes in outcome measures after low level laser therapy T2DM with Peripheral neuropathy.

Case	FBS pre (mg/dl)	FBS post (mg/dl)	PPBS pre (mg/dl)	PPBS post (mg/dl)	VAS pre	VAS post	MNSI pre	MNSI post	VPT pre	VPT post	Temperature pre	Temperature post
Case 1	147	128	155	158	7	2	7	4	45	26	28.1	31.4
Case 2	260	191	197	152	6	1	7.5	3	38	29	31.2	31.3
Case 3	131	136	215	196	6	0	5	4	28	22	32.1	31.2
Case 4	185	136	153	162	7	1	6	2	31	21	26.3	30.5
Case 5	191	152	241	198	5	2	4	2.5	33	30	27.3	31.5
Case 6	261	179	284	219	8	2	3.5	3.5	32	24	30.2	31.8
Case 7	155	121	238	198	7	2	6.5	3	35	26	31.4	32.2
Case 8	321	141	368	198	6	1	7	2	43	32	31.12	33.2
Case 9	138	109	120	141	8	2	6	2.5	26	19	28.3	33.2
Case 10	198	138	210	191	6	1	5.5	2	42	33	30.2	31.7
Case 11	203	198	314	262	7	2	4	4	26	21	33.4	32.5
Case 12	141	256	214	312	6	0	7	0	35	23	31.21	32.8
Case 13	210	198	300	231	7	1	5	2	32	24	26.3	29.4
Case 14	252	291	529	324	6	2	6	2.5	29	25	31.34	33.2
Case 15	109	139	213	242	7	0	5	2.5	25	18	33.2	31.2
Case 16	103	98	173	169	6	1	5	3.5	24	21	30.2	32.4
Case 17	226	218	332	242	5	2	6	2	33	25	28.3	31.3
Case 18	112	109	193	157	7	1	6	3	35	30	31.1	32.2
Case 19	162	125	163	155	6	0	3	3.5	29	23	29.1	30.3